Logo image of XFIN

EXCELFIN ACQUISITION CORP-A (XFIN) Stock Fundamental Analysis

USA - NASDAQ:XFIN - US30069X1028 - Common Stock

9.24 USD
-2.05 (-18.16%)
Last: 10/1/2024, 8:00:02 PM
10.7 USD
+1.46 (+15.8%)
After Hours: 10/1/2024, 8:00:02 PM
Fundamental Rating

1

Taking everything into account, XFIN scores 1 out of 10 in our fundamental rating. XFIN was compared to 0 industry peers in the Unkown industry. XFIN has a bad profitability rating. Also its financial health evaluation is rather negative. XFIN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

XFIN had negative earnings in the past year.
XFIN had a negative operating cash flow in the past year.
XFIN Yearly Net Income VS EBIT VS OCF VS FCFXFIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -2M -4M -6M

1.2 Ratios

Industry RankSector Rank
ROA -27.85%
ROE -194.92%
ROIC N/A
ROA(3y)-4.55%
ROA(5y)N/A
ROE(3y)-9.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XFIN Yearly ROA, ROE, ROICXFIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -10 -20 -30

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for XFIN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XFIN Yearly Profit, Operating, Gross MarginsXFIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

XFIN has less shares outstanding than it did 1 year ago.
XFIN has a worse debt/assets ratio than last year.
XFIN Yearly Shares OutstandingXFIN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
XFIN Yearly Total Debt VS Total AssetsXFIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 6.40 indicates that XFIN is not in any danger for bankruptcy at the moment.
XFIN has a Debt/Equity ratio of 0.52. This is a neutral value indicating XFIN is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z 6.4
ROIC/WACCN/A
WACCN/A
XFIN Yearly LT Debt VS Equity VS FCFXFIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.02 indicates that XFIN may have some problems paying its short term obligations.
A Quick Ratio of 0.02 indicates that XFIN may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
XFIN Yearly Current Assets VS Current LiabilitesXFIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for XFIN have decreased strongly by -723.60% in the last year.
EPS 1Y (TTM)-723.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

XFIN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XFIN Price Earnings VS Forward Price EarningsXFIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XFIN Per share dataXFIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

XFIN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EXCELFIN ACQUISITION CORP-A

NASDAQ:XFIN (10/1/2024, 8:00:02 PM)

After market: 10.7 +1.46 (+15.8%)

9.24

-2.05 (-18.16%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.67%
Inst Owner Change0%
Ins Owners22.16%
Ins Owner Change0%
Market Cap239.78M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 95.8
P/tB 95.8
EV/EBITDA N/A
EPS(TTM)-0.74
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0
BVpS0.1
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.85%
ROE -194.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.55%
ROA(5y)N/A
ROE(3y)-9.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 6.4
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-723.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.45%
OCF growth 3YN/A
OCF growth 5YN/A